Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,358.00
(
-1.51%
)
Dow Jones
50,063.46
(
0.00%
)
Brent Oil
105.56
(
1.32%
)
Bitcoin
80,517.99
(
-0.66%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 143360

Monday, 10/08/2012 7:23:12 PM

Monday, October 08, 2012 7:23:12 PM

Post# of 257566
Research report on RA states what many investors already knew:

http://finance.yahoo.com/news/rheumatologists-continue-prefer-enbrel-humira-130000072.html

Rheumatologists Continue to Prefer Enbrel and Humira as Both Their First and Second Line Biologic Agents and the Combined Formulations of Orencia as the Dominant Third Line Agent

Save yourself the money and don’t buy the report!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today